Digital Content 
NEWS #PharmaBuzz
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112862/28908/en/Tonix-Pharmaceuticals-Announces-On-line-Publication-of-Phase-3-RESILIENT-Trial-Results-of-TNX-102-SL-for-Fibromyalgia-in-the-Peer-Reviewed-Journal-Pain-Medicine.html
16 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/16/3099705/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-the-Annual-European-Congress-of-Rheumatology-EULAR-2025.html
07 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/07/3056558/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-the-American-Academy-of-Pain-Medicine-AAPM-2025-Annual-Meeting.html
04 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/04/3036329/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-7th-International-Congress-on-Controversies-in-Fibromyalgia.html
23 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/23/2951242/28908/en/Tonix-Pharmaceuticals-Announces-Data-Presentations-on-TNX-102-SL-for-Fibromyalgia-at-the-11th-Global-Conference-on-Pharmaceutics-and-Novel-Drug-Delivery-Systems-PDDS-2024.html
28 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/28/2936884/28908/en/Tonix-Pharmaceuticals-Presented-Data-and-Analyses-of-TNX-102-SL-Treatment-Effects-on-Fibromyalgia-at-the-2024-Military-Health-System-Research-Symposium-MHSRS.html
Share 